CN1733074A - Externally applied medicine for treating dermatosis - Google Patents
Externally applied medicine for treating dermatosis Download PDFInfo
- Publication number
- CN1733074A CN1733074A CNA2005100912681A CN200510091268A CN1733074A CN 1733074 A CN1733074 A CN 1733074A CN A2005100912681 A CNA2005100912681 A CN A2005100912681A CN 200510091268 A CN200510091268 A CN 200510091268A CN 1733074 A CN1733074 A CN 1733074A
- Authority
- CN
- China
- Prior art keywords
- grams
- gram
- radix
- powder
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention discloses an externally applied medicine for treating dermatosis, which is prepared from Chinese medicinal herbs including honeysuckle flower, baikal skullcap root, Chinese angelica root, root of red rooted saliva, siberian cocklebur fruit, achyranthes and cyathula root, Chinese ephedra, Schizonepeta tenuifolia, cassia twig, pearl powder through cleaning, heating, drying, disintegrating, grease making and sterilizing.
Description
The dermopathic external used medicine of a kind of treatment of the present invention relates to pharmaceutical field, it specifically is raw material with the Chinese herbal medicine, through big gun process, dry, pulverize, external preparation for skin powder, unguentum that Technologies such as system cream, sterilization are made, the invention still further relates to the preparation method of this powder unguentum.
The skin and the mucosal infections disease that are caused by the source of disease microorganism are human threats greatly, and mucocutaneous be one of the area of liability of multiple pathogen, the skin pruritus that causes thus, eczema, beriberi, Yin Xiao disease, vaginitis, tinea corporis and cruris are common clinical, and relapse rate is high, and often bring out multiple secondary infection disease, bring unmentionable pain to people.Greatly developing along with the industrialization industry in recent years, mucocutaneous infections sharply rises, its reason may be in a large amount of listings of chemical substance, and air pollution is relevant to multiple factors such as the infringement of human body and patient's itself body constitution, nutritional status, dysfunction of nervous regulation, metabolism disorders.Though mucocutaneous disease is safe from harm to life for the moment, can bring in various degree the misery or affect and imitate rule with work orthobiosis of feeling embarrassed to mention to the patient.The dermopathic external used medicine powder of a kind of treatment of the present invention unguentum, part by skin or mucosa is coated with to touch administration or light and sucks smoked the treatment, the combination of inner and outside, suction reaches whole body meridian and relaxes logical, smear direct inhibition or deactivation antibacterial and fungus colony, thereby improve self resistance against diseases effectively, prevent the breeding of source of disease microorganism, propagate, reach the purpose of antibacterial anti-inflammatory, killing parasites for relieving itching, removing heat from blood dehumidifying and disease-prevention health and correction immune imbalance.
The object of the present invention is to provide and a kind ofly have putrefaction-removing granulation-promoting, detoxicating, killing bacteria, removing heat from blood dehumidifying and directly act on the part and suck the smoked logical whole body passages through which vital energy circulates for the treatment of, relax, correct the external used medicine of immune imbalance.Main component is Flos Lonicerae, Radix Scutellariae, Radix Angelicae Sinensis, Radix Salviae Miltiorrhizae, Fructus Xanthii, Radix Achyranthis Bidentatae, Herba Ephedrae, Herba Schizonepetae, Ramulus Cinnamomi, Margarita powder etc. ten flavor herbal raw materials, processs method and modern science technology is made powder, unguentum through special big gun.The direct administration of skin reaches local putrefaction-removing granulation-promoting, detoxicating, killing bacteria, suck smoked the treatment, obviously the human body immunity improving function enters intravital drug smell and can quicken interior environment metabolism, promote the regeneration and restoration of skin surface necrosis, make various source of disease infected by microbes disease quickly-healings.
Another object of the present invention provides a kind of preparation method for the treatment of dermopathic external used medicine.It is characterized in that earlier Flos Lonicerae, Radix Scutellariae, Radix Angelicae Sinensis, Radix Salviae Miltiorrhizae, Fructus Xanthii, Radix Achyranthis Bidentatae, Herba Ephedrae, Herba Schizonepetae, the Ramulus Cinnamomi nine that will clean flavor be single putting the iron pan internal heating one by one and being stirred to into black wood charcoal, flame-out, spray 10% filtrate that decocts with water with the Radix Angelicae Dahuricae, Rhizoma Chuanxiong, Fructus Psoraleae three flavors, stir, cool, drying, it is standby to be crushed to 120 mesh sieve fine powders; Weigh the proportioning weight and the Margarita powder mix homogeneously of every herbal medicine, packing gets powder; Other gets powder and vaseline and is mixed with into 30% ointment, ointment, packing, G
60Radiation sterilizing gets product.
The characteristics of a kind of external use medicine for treating dermatosis thing of the present invention are partial smearing or light and suck the smoked nose administration for the treatment of, the logical whole body passages through which vital energy circulates that can relax, inside and outside take into account, easy to use, lasting medicine, side effect is little, can see good result in a short time, better to the therapeutic effect of chronic dermatosis.
Medicine of the present invention shows through antibacterial tests and skin irritation test, carry out the repeatedly skin irritation test of staphylococcus aureus and White Rabbit single-use skin irritant test, Cavia porcellus according to Ministry of Public Health " disinfection technology standard " (version in 2002) method, the result shows strong, the no skin irritation of a kind of treatment dermatosis external powder cream antibacterial antiplaque agent power that provides by the related standards scoring.Result of the test sees Table 1, table 2 and table 3.
Table 1 Lu Hu dermatosis externally used paste is to staphylococcus aureus bacteriostatic test result
Print inhibition zone diameter (mm) bacterial concentration negative control is antibacterial
Test sequence number 1234 meansigma methodss (cfu/ml) ring diameters (mm)
1 13.0 14.0 15.0 16.0 14.5 180 * 10
4Do not have
2 14.0 14.0 15.0 15.0 14.5 165 * 10
4Do not have
3 13.0 15.0 16.0 14.0 14.5 175 * 10
4Do not have
Meansigma methods 14.5 173 * 10
4Do not have
Conclusion, product of the present invention as can be seen from Table 1 has antibacterial action preferably to three tests of staphylococcus aureus.
Table 2 Lu Hu dermatosis externally used paste is to irritant reaction of White Rabbit skin
1h 24h 48h
The contrast of the same product control sample of numbering animality complicated variant control sample
(kg) the total red water of the total red water of the total red water of the total red water of the total red water of red water is total
Speckle is swollen to divide that speckle is swollen to divide that speckle is swollen to divide that speckle is swollen to divide that speckle is swollen to divide that speckle is swollen to be divided
1 male 2.2 000 000 000 000 000 000
2 male 2.2 000 000 000 000 000 000
3 male 2.6 000 000 000 000 000 000
Integral mean value 000000
Conclusion, product of the present invention as can be seen from Table 2 belongs to nonirritant to the White Rabbit skin irritation.
Table 3 Lu Hu dermatosis externally used paste is tested the guinea pig skin allergy
The group number of animals is induced the erythematous response intensity edema response strength sensitization rate when observing that excites
(h) 0123401234 (%) between (only) dosage dosage
Tried the former cream 24h 16,/16 0000 16,/16 00000 of 16 former cream
Thing group 48h 16,/16 0000 16,/16 00000
Negative to 16/former cream 24h 16,/16 0000 16,/16 00000
According to group 48h 16,/16 0000 16,/16 00000
Positive in 16 8% 2% 24h 6,/16 6,/16 4,/16 00 16,/16 0000 62.5
According to group 48h 6,/16 6,/16 4,/16 00 16,/16 0000 62.5
Conclusion, product of the present invention as can be seen from Table 3 to the sensitization of skin intensity of experimental animal Cavia porcellus for not seeing skin allergic reaction.
Medicine of the present invention is treated follow-up observation to 210 routine patients, and wherein sicken age was at 1 month to 5 years, and administration time 10 to 90 days, the unguentum of a packing specification are 20 grams, smear 2 times on the one according to the size of skin affected part area; One in powder is packaged as 10 grams, lights smoked the treatment for 1 time on the one, prohibits sexual life during the medication, avoids maror.Cure 82 examples, account for 39.1%, produce effects 103 examples account for 49.0%; Effective 17 examples account for 8.1%; Invalid 8 examples account for 3.8%, and total effective rate reaches 96.2%.Therefore, invent the external of a kind of dermatosis powder unguentum and smear and suck smoked the treatment, the combination of inner and outside, improve healthy energy, consolidate the training source, curative effect is lasting, effect is obvious, be difficult for recurrence, chronic skin patient and medical market service are had great significance, put on market generation considerable economic and social benefit.
Claims (3)
1, the dermopathic external used medicine of a kind of treatment is characterized in that it is the topical agent of being made by following herbal raw material proportioning:
Flos Lonicerae 12 gram Radix Scutellariaes 10 gram Radix Angelicae Sinensis 10 gram Radix Salviae Miltiorrhizaes 10 grams
Fructus Xanthii 10 gram Radix Achyranthis Bidentataes 20 gram Herba Ephedraes 20 gram Herba Schizonepetae 10 grams
Ramulus Cinnamomi 10 gram Margarita powder 8 grams.
2, the dermopathic external used medicine of a kind of treatment according to claim 1 is characterized in that said dosage form is external preparation for skin powder or ointment.
3, a kind of preparation method for preparing the treatment external use medicine for treating dermatosis thing of aforesaid right requirement 1 or 2, it is characterized in that earlier Flos Lonicerae 12 grams, Radix Scutellariae 10 grams, Radix Angelicae Sinensis 10 grams, Radix Salviae Miltiorrhizae 10 grams, Fructus Xanthii 10 grams, Radix Achyranthis Bidentatae 20 grams, Herba Ephedrae 20 grams, Herba Schizonepetae 10 grams, Ramulus Cinnamomi 10 grams nine that will clean flavor be single putting the iron pan internal heating one by one and being stirred to into black wood charcoal, flame-out, spray 10% filtrate that decocts with water with the Radix Angelicae Dahuricae, Rhizoma Chuanxiong, each 10 gram of Fructus Psoraleae, stir, cool, drying, it is standby to be crushed to 120 mesh sieve fine powders; Weigh the proportioning weight and the Margarita powder 8 gram mix homogeneously of every herbal medicine, packing promptly gets powder; Also desirable powder and vaseline are mixed with into 30% ointment, ointment; Packing, G
60Radiation sterilizing gets product.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100912681A CN100342868C (en) | 2005-08-19 | 2005-08-19 | Externally applied medicine for treating dermatosis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100912681A CN100342868C (en) | 2005-08-19 | 2005-08-19 | Externally applied medicine for treating dermatosis |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1733074A true CN1733074A (en) | 2006-02-15 |
CN100342868C CN100342868C (en) | 2007-10-17 |
Family
ID=36075828
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005100912681A Expired - Fee Related CN100342868C (en) | 2005-08-19 | 2005-08-19 | Externally applied medicine for treating dermatosis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100342868C (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101249190B (en) * | 2008-03-28 | 2010-12-15 | 李春华 | Anti-inflammation sterilizing Chinese medicine compound externally used coating liquid and method of preparing the same |
CN103417781A (en) * | 2013-08-10 | 2013-12-04 | 济南伟传信息技术有限公司 | Traditional Chinese medicine for treating surgical wounds |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1085797A (en) * | 1993-07-24 | 1994-04-27 | 邹有安 | Eliminating inflammation and expelling toxin sore treatment ointment and preparation method thereof |
-
2005
- 2005-08-19 CN CNB2005100912681A patent/CN100342868C/en not_active Expired - Fee Related
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101249190B (en) * | 2008-03-28 | 2010-12-15 | 李春华 | Anti-inflammation sterilizing Chinese medicine compound externally used coating liquid and method of preparing the same |
CN103417781A (en) * | 2013-08-10 | 2013-12-04 | 济南伟传信息技术有限公司 | Traditional Chinese medicine for treating surgical wounds |
CN103417781B (en) * | 2013-08-10 | 2015-09-09 | 济南伟传信息技术有限公司 | A kind of Chinese medicine for the treatment of surgical wound |
Also Published As
Publication number | Publication date |
---|---|
CN100342868C (en) | 2007-10-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111097040A (en) | Antiviral lung-heat clearing peptide | |
CN102512490A (en) | Aromatherapy essential oil for treating gynecological inflammation and essential oil aromatherapy patch | |
CN112569331A (en) | Traditional Chinese medicine composition for preventing new coronavirus, preparation method and application | |
CN105802255A (en) | Energy-saving environment-friendly LED ceiling lamp | |
CN106729070A (en) | A kind of external application energy gauging for mitigating arthralgia and preparation method thereof | |
CN103055031B (en) | Pure Chinese medicinal composition for treating lime disease of bees and preparation method of pure Chinese medicinal composition | |
CN1879788A (en) | Virus-clearing capsule | |
CN100342868C (en) | Externally applied medicine for treating dermatosis | |
CN102274355A (en) | Externally applied medicament for treating foot-and-mouth disease in pigs | |
CN1281228C (en) | Medicine for hyperplasia of mammary glands and its preparation | |
CN102357148B (en) | Pure Chinese herbal composition for treating Riemerella anatipestifer disease and preparation method thereof | |
CN1108810C (en) | Medicine for treating psoriasis and preparing process thereof | |
CN101036701A (en) | Chinese traditional medicine lotion | |
CN1223132A (en) | Medicine for curing dermatosis | |
CN102008586A (en) | Effective drug for treating skin disease | |
CN103055152B (en) | Pure Chinese medicinal composition for treating fin rot of fishes and shrimps and preparation method thereof | |
CN1167455C (en) | Medicine for treating acne and its preparing process | |
CN102727639B (en) | External-use medicine for treating venereal disease | |
CN102670804B (en) | Compound propolis composition for treating poultry dysentery and preparation method thereof | |
CN111345531A (en) | Rhinitis health care mask | |
CN104352911B (en) | A kind of composition for treating domestic animal breathing problem and preparation method thereof | |
CN1048173C (en) | Venereal disease curing powder medicine and method for preparing same | |
CN102824456A (en) | Specific medicine for treating animal aftosa | |
CN106390166A (en) | Air freshener with sterilizing effect and preparation method thereof | |
CN1305508C (en) | Pill for treating coronary heart disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |